Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Clinical experience with psychoanalytic post-termination meetings

J Schachter, G C Martin, M J Gundle

    The International Journal of Psycho-Analysis
    |March 26, 1998
    PubMed
    Summary

    Post-termination meetings between analysts and patients can be beneficial, aiding further growth and solidifying analytic gains. This challenges the assumption that all post-treatment contact is harmful.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Randomized, double-blind, phase III LEAP-003 study of first-line lenvatinib plus pembrolizumab versus placebo plus pembrolizumab for unresectable or metastatic melanoma.

    Annals of oncology : official journal of the European Society for Medical Oncology·2025
    Same author

    Efficacy of adjuvant therapy in patients with stage IIIA cutaneous melanoma.

    Annals of oncology : official journal of the European Society for Medical Oncology·2025
    Same author

    Pembrolizumab versus ipilimumab for advanced melanoma: 10-year follow-up of the phase III KEYNOTE-006 study.

    Annals of oncology : official journal of the European Society for Medical Oncology·2024
    Same author

    Corrigendum to 'Pembrolizumab for locally advanced and recurrent/metastatic cutaneous squamous cell carcinoma (KEYNOTE-629 study): an open-label, nonrandomized, multicenter, phase II trial: [Annals of Oncology Volume 32, Issue 10, October 2021, Pages 1276-1285].

    Annals of oncology : official journal of the European Society for Medical Oncology·2022
    Same author

    Antitumor activity of ipilimumab or BRAF ± MEK inhibition after pembrolizumab treatment in patients with advanced melanoma: analysis from KEYNOTE-006.

    Annals of oncology : official journal of the European Society for Medical Oncology·2021
    Same author

    Pembrolizumab for locally advanced and recurrent/metastatic cutaneous squamous cell carcinoma (KEYNOTE-629 study): an open-label, nonrandomized, multicenter, phase II trial.

    Annals of oncology : official journal of the European Society for Medical Oncology·2021

    Area of Science:

    • Psychology
    • Psychoanalysis

    Background:

    • The traditional view in psychoanalysis often discourages post-termination contact between analyst and patient, assuming it is detrimental unless part of further treatment.
    • This study examines the controversial issue of the appropriate relationship and interaction between analyst and patient after the formal termination of therapy.

    Observation:

    • Three case studies involving post-termination meetings were analyzed to understand their impact on patients.
    • Observations focused on how these meetings influenced the patient's therapeutic process and outcomes post-termination.

    Findings:

    • Post-termination meetings facilitated re-engagement in treatment for one patient, leading to significant growth.
    • In other cases, these meetings helped patients process mourning for the analyst and achieve further analytic gains.

    Related Experiment Videos

  • The overall impression was that post-termination contacts were helpful, contradicting the assumption that such contact is inherently harmful.

    • Implications:

    • Post-termination meetings may stabilize analytic gains and provide a valuable later perspective on the therapeutic outcome.
    • These meetings offer opportunities for further analytic work and a more inclusive evaluation of the entire analysis.
    • The findings encourage exploration and reporting of such meetings to build clinical data and challenge existing assumptions.